Avanos Medical (AVNS) Price to Sales (2014 - 2026)

Avanos Medical has disclosed Price to Sales across 13 years of filings, most recently posting 3.59 for Q1 2026.

• In Q1 2026, Price to Sales fell 9.27% year-over-year to 3.59; the TTM figure through Mar 2026 stood at 0.91 (down 4.99% YoY), while the FY2025 annual figure was 0.74, down 30.06% from the prior year.
• Price to Sales came in at 3.59 for Q1 2026 at Avanos Medical, up from 2.88 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 8.71 in Q1 2023 to a low of 2.88 in Q4 2025.
• Average Price to Sales over 5 years is 5.51, with a median of 5.52 recorded in 2024.
• Year-over-year, Price to Sales plunged 85.15% in 2022 and climbed 18.26% in 2024.
• Over 5 years, Price to Sales stood at 6.93 in 2022, then declined by 13.8% to 5.98 in 2023, then plunged by 31.83% to 4.07 in 2024, then slipped by 29.21% to 2.88 in 2025, then increased by 24.44% to 3.59 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 3.59 in Q1 2026, 2.88 in Q4 2025, and 3.02 in Q3 2025.